• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchBone Biologics
    Picture of Bone Biologics logo

    BBLG — Bone Biologics News Story

    $0.390.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    • Market Cap
      $1.09m
    • Enterprise Value
      -$2.94m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BBLG Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BBLG Dividends
    All News

    NASDAQ RESUMED AT 10:43 AM

    Picture of Bone Biologics logoBone Biologics
    14/01/2022 15:43
    NASDAQ RESUMED  BBLG.O  AT 10:43 AM
    

    Recent news on Bone Biologics

    See all news
    • Bone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview

      10/08/2026 22:29
    • Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months

      23/12/2025 13:19
    • Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook

      04/09/2025 12:01
    • Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview

      15/08/2025 21:07
    • Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview

      05/08/2025 21:32

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.